| let-7a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| let-7b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| let-7d |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| let-7f |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| let-7g |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| let-7i |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-103 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-106a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-106b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-107 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-10a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-125a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-127 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-128b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-130a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-132 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-133a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-133b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-140 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-141 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-146b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-148a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-149 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-152 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-15a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-15b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-16 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-17 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-181b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-181d |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-182 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-185 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-186 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-187 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-18a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-18b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-191 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-192 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-193b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-194 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-195 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-196b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-199a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-200a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-200a* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-203 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-205 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-206 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-20a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-20b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-210 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-212 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-214 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-215 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-22 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-221 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-222 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-224 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-23a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-23b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-25 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-26a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-28 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-29a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-29b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-301 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-30a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-30e |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-320 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-323 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-324 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-328 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-331 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-339 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-342 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-345 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-34c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-362 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-368 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-373* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-374 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-375 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-376a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-378 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-409 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-410 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-411 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-421 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-422a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-424 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-429 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-431 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-432 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-433 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-450 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-451 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
18645025 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-484 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-486 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-487a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-487b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-489 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-493 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-495 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-503 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-532 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-542 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-550 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-557 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-565 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-574 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-584 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-590 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-594 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-615 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-637 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-654 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-660 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-7 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-9 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-93 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| miR-96 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18645025 |
|
| miR-99b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18645025 |
|
| let-7a |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Resistant |
Low |
18758960 |
|
| let-7a |
Doxorubicin (Adriamycin) |
squamous carcinoma |
Resistant |
Low |
18758960 |
|
| miR-34 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
18803879 |
|
| miR-1 |
Doxorubicin (Adriamycin) |
lung cancer |
Sensitive |
Low |
18818206 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-106a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-106b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-108a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-125a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-130a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-141 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-183 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-193a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-200a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-203 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
18971180 |
|
| miR-20b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-210 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-22 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-221 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-222 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-23a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-25 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-301 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-339 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-421 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-590 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-680 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-92 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| miR-93 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| mmu-miR-20b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| mmu-miR-703 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| rno-mir-301a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| rno-mir-93 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
18971180 |
|
| let-7e |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-106a |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-126 |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-132 |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-142 |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
ovarian cancer |
Resistant |
High |
19237188 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
ovarian cancer |
Sensitive |
High |
19237188 |
|
| let-7e |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| let-7e* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| let-7f |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| let-7g |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| let-7i |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-1 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-101* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-10a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-10b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-125b-1* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-128a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-128b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-130b* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-132 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-135a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-135b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
19412672 |
|
| miR-140 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-141 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-141* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-142 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-143* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-146a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-146b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-148a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-151 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-153 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-154* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-15a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-15b* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-16 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-181a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-181c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-181d |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-182* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-186 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-18a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-190 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-192* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-193a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-196a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-196b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-199b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-19a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-19b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-19b-1* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-200a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-205 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-206 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-214* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-216a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-216b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-219 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-220 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-221 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-25 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-26a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-26a-MM1 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-28 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-299 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-29a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-29c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-301b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-302a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-302c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-302c* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-30a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-30b* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-30d* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-30e |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-30e* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-31* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-32 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-320 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-330 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-331 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-339 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-33a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-33a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-33b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-345 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-34b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-361 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-367 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-369 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-370 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-373 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-373* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-374a* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-376c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-410 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-412 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-425 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-429 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-431 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-448 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-450a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-451 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-453 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-454 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-491 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-496 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-497 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-499 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-502 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-505 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-509 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-514 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-517a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-517b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-517c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-519b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520d |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520g |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-520h |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-526b* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-532 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-539 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-541* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-542 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-545 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-548a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-555 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-560 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-563 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-568 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-569 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-571 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-576 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-578 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-582 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-586 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-587 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-588 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-589* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-590 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-591 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-592 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-593* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-601 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-605 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-606 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-613 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-629 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-633 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-639 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-643 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-649 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-651 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-652 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-655 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-660 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-662 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-7-1* |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-758 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-760 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-765 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-767 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-769 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-876 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-886 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-888 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-92a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-93 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-96 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-99a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
19412672 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
colorectal cancer |
Sensitive |
Low |
19458054 |
|
| miR-122 |
Doxorubicin (Adriamycin) |
hepatocarcinoma |
Sensitive |
Low |
19584283 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
19633292 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
19839049 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
19839049 |
|
| miR-326 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
19883630 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
esophageal squamous cell carcinoma |
Resistant |
Low |
19960259 |
|
| miR-181b |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Resistant |
Low |
20023698 |
|
| miR-125a |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-127 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-134 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-143 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-195 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-216a |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-217 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-299 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-324 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-329 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-376a |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-376c |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-379 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-382 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-409 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-432 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-487b |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-494 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-495 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
High |
20371173 |
|
| miR-654 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-99b |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
High |
20371173 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
20371610 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
20390345 |
|
| miR-296 |
Doxorubicin (Adriamycin) |
esophageal squamous cell carcinoma |
Resistant |
Low |
20485139 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
hepatocarcinoma |
Sensitive |
Low |
20501828 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
21055388 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
leukaemia |
Sensitive |
Low |
21070600 |
|
| miR-331 |
Doxorubicin (Adriamycin) |
leukaemia |
Sensitive |
Low |
21070600 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
21114921 |
|
| let-7f |
Doxorubicin (Adriamycin) |
leukemia |
Resistant |
High |
21122348 |
|
| let-7g |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
leukemia |
Resistant |
High |
21122348 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-221 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-424 |
Doxorubicin (Adriamycin) |
leukemia |
Resistant |
High |
21122348 |
|
| miR-451 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-563 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-98 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
High |
21122348 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
esophageal cancer |
Resistant |
High |
21248297 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
esophageal cancer |
Resistant |
High |
21248297 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
esophageal cancer |
Sensitive |
High |
21248297 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
bladder cancer |
Resistant |
Low |
21468550 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
21569481 |
|
| miR-122 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
21750653 |
|
| miR-122 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
21802841 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
21820606 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
pediatric acute promyelocytic leukemia |
Resistant |
Low |
21880154 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-135b |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-141 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-182 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-183 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-210 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-30b |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-30d |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-429 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-881* |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Sensitive |
High |
21899346 |
|
| miR-96 |
Doxorubicin (Adriamycin) |
ehrlich ascites tumor |
Resistant |
High |
21899346 |
|
| miR-128 |
Doxorubicin (Adriamycin) |
breast tumor-initiating cells |
Sensitive |
Low |
21953503 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
ewing sarcoma |
Sensitive |
Low |
21960059 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
22101791 |
|
| miR-17-92 |
Doxorubicin (Adriamycin) |
mantle cell lymphoma |
Resistant |
Low |
22116552 |
|
| miR-1915 |
Doxorubicin (Adriamycin) |
colorectal carcinoma |
Sensitive |
Low |
22121083 |
|
| miR-297 |
Doxorubicin (Adriamycin) |
colorectal cancer |
Sensitive |
High |
22121083 |
|
| miR-128-2 |
Doxorubicin (Adriamycin) |
non-small-cell lung cancer |
Resistant |
Low |
22193543 |
|
| miR-122 |
Doxorubicin (Adriamycin) |
cutaneous T-cell lymphoma |
Resistant |
Low |
22235305 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
ovarian cancer |
Sensitive |
Low |
22498306 |
|
| miR-126 |
Doxorubicin (Adriamycin) |
non-small cell lung cancer |
Sensitive |
Low |
22510476 |
|
| miR-298 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
22521303 |
|
| miR-297 |
Doxorubicin (Adriamycin) |
colorectal carcinoma |
Sensitive |
Low |
22676135 |
|
| miR-708 |
Doxorubicin (Adriamycin) |
ewing sarcoma |
Associated |
Low |
22723308 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
colorectal cancer |
Sensitive |
Low |
22903020 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
chronic myeloid leukemia |
Resistant |
Low |
22957792 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23085450 |
|
| miR-137 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23178914 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23209748 |
|
| miR-146a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-146b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-181d |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-186* |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-1908 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-1915 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-193b* |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-194 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-22 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-23a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-26b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23229111 |
|
| miR-300 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-30b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-30c |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-3183 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4258 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4285 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-4311 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-584 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-612 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-630 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-99b* |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23229111 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
diffuse large B-cell lymphoma |
Resistant |
Low |
23275230 |
|
| miR-30a* |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23340433 |
|
| miR-30c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23340433 |
|
| hsa-novel-miR-12 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| hsa-novel-miR-13 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-14 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-mir-15 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-17 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-19 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-25 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-26 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-mir-27 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novelmiR-35 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-41 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-43 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-5 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-50 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-51 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-57 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-58 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-64 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-65 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-71 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-miR-72 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| hsa-novel-mir-8 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-1255a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-1269b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-1277 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-1293 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-139 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-196a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-203 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-2116 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-2277 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-2682 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-296 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-302b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-3117 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-3186 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-335 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-338 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-362 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-3622a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
23359607 |
|
| miR-3654 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-365a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-365b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-3660 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-3674 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-3679 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-3687 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-3910 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4426 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4427 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4448 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4454 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4485 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4488 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4501 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4508 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-4687 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-486 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-500a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-500b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-548h |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-551b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-577 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-642a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-720 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-877 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-944 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
High |
23359607 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23364795 |
|
| miR-135 |
Doxorubicin (Adriamycin) |
cervical carcinoma, colon cancer |
Sensitive |
Low |
23438844 |
|
| miR-138 |
Doxorubicin (Adriamycin) |
cervical carcinoma, colon cancer |
Sensitive |
Low |
23438844 |
|
| miR-205 |
Doxorubicin (Adriamycin) |
melanoma |
Sensitive |
Low |
23447575 |
|
| let-7c |
Doxorubicin (Adriamycin) |
The Ewing sarcoma/primitive neuroectodermal tumor |
Resistant |
High |
23497288 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
ewing sarcoma |
Resistant |
Low |
23497288 |
|
| miR-93 |
Doxorubicin (Adriamycin) |
The Ewing sarcoma/primitive neuroectodermal tumor |
Resistant |
High |
23497288 |
|
| miR-1224 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1229 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1238 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-1273d |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-129 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-133b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-190 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-197 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-210 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-22 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3131 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3149 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-3162 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-32 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4701 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4728 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-4763 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-486 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
23525256 |
|
| miR-501 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-5096 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-532 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-615 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-766 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-877 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
23525256 |
|
| miR-195 |
Doxorubicin (Adriamycin) |
colon cancer |
Sensitive |
Low |
23526568 |
|
| miR-128 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
23526655 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
23527297 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23546450 |
|
| miR-19a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
23603256 |
|
| miR-19b |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
23603256 |
|
| miR-1291 |
Doxorubicin (Adriamycin) |
- |
Sensitive |
Low |
23686318 |
|
| miR-214 |
Doxorubicin (Adriamycin) |
esophageal squamous cell carcinoma |
Resistant |
Low |
23721345 |
|
| miR-483 |
Doxorubicin (Adriamycin) |
esophageal squamous cell carcinoma |
Resistant |
Low |
23721345 |
|
| miR-223 |
Doxorubicin (Adriamycin) |
esophageal adenocarcinoma |
Sensitive |
Low |
23757351 |
|
| miR-195 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23760062 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
chronic myeloid leukemia |
Resistant |
Low |
23834154 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
esophageal cancer |
Resistant |
Low |
23838916 |
|
| miR-508 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
23893241 |
|
| miR-223 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
23925649 |
|
| miR-106a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
23932924 |
|
| miR-137 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
Low |
23934188 |
|
| miR-133a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
23969999 |
|
| miR-196a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
23994196 |
|
| miR-222 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
23994196 |
|
| miR-29a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
23994196 |
|
| miR-30a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
23994196 |
|
| miR-149 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
24007627 |
|
| miR-187 |
Doxorubicin (Adriamycin) |
peripheral T-cell lymphoma |
Resistant |
Low |
24104394 |
|
| miR-101 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
24211739 |
|
| miR-1269 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-127 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-135b |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-146a |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-149 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-184 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-202* |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-299 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-3117 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-323 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-338 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-3681 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-3681* |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-369 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-375 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-376a |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-376b |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-376c |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-377 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-379 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-380 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-381 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
Low |
24303078 |
|
| miR-383* |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-409 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-410 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-411 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-487b |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-488 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-489 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-494 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-495 |
Doxorubicin (Adriamycin) |
leukemia |
Sensitive |
Low |
24303078 |
|
| miR-508 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-509 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-514 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-584 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Resistant |
High |
24303078 |
|
| miR-889 |
Doxorubicin (Adriamycin) |
chronic myelogenous leukemia |
Sensitive |
High |
24303078 |
|
| miR-146a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-146b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-15a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-16 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-181d |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-194 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-30b |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Resistant |
High |
24314246 |
|
| miR-520h |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24316511 |
|
| miR-221 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Resistant |
Low |
24324033 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24335172 |
|
| miR-223 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24400121 |
|
| miR-16 |
Doxorubicin (Adriamycin) |
lung adenocarcinoma |
Sensitive |
Low |
24462518 |
|
| miR-296 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24462518 |
|
| miR-30c |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24519092 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Resistant |
Low |
24559685 |
|
| miR-26b |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
24565101 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
triple negative breast cancer |
Sensitive |
Low |
24565525 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24606718 |
|
| miR-22 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
24609901 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24740415 |
|
| miR-17 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24740415 |
|
| miR-222 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24740415 |
|
| miR-342 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24740415 |
|
| miR-451 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
24740415 |
|
| miR-181b |
Doxorubicin (Adriamycin) |
acute myeloid leukemia |
Sensitive |
Low |
24756163 |
|
| let-7e |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24759738 |
|
| miR-100 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24759738 |
|
| miR-1246 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
24759738 |
|
| miR-125a |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24759738 |
|
| miR-1273g |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
24759738 |
|
| miR-148a |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
24759738 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24759738 |
|
| miR-181b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
24759738 |
|
| miR-342 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
24759738 |
|
| miR-378a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
24759738 |
|
| miR-425 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
24759738 |
|
| miR-4430 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
24759738 |
|
| miR-494 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
24759738 |
|
| miR-7 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
24759738 |
|
| miR-99b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24759738 |
|
| miR-185 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
24763054 |
|
| miR-200b |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
Low |
24769353 |
|
| miR-489 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24786471 |
|
| miR-130a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24788655 |
|
| miR-451a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
24788655 |
|
| miR-34c |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
24802328 |
|
| miR-1236 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-1256 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-129 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Sensitive |
High |
24858372 |
|
| miR-138-1* |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-187 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-191* |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-214* |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-224 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-29b-2* |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-33a |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Sensitive |
High |
24858372 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Sensitive |
High |
24858372 |
|
| miR-520 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-542 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Sensitive |
High |
24858372 |
|
| miR-876 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Sensitive |
High |
24858372 |
|
| miR-Plus-A1031 |
Doxorubicin (Adriamycin) |
diffuse large B cell lymphoma (DLBCL) |
Resistant |
High |
24858372 |
|
| miR-424 |
Doxorubicin (Adriamycin) |
cancer |
Resistant |
Low |
24967963 |
|
| miR-17 |
Doxorubicin (Adriamycin) |
synovial sarcoma |
Resistant |
Low |
24989082 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
25009614 |
|
| miR-101 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Resistant |
Low |
25013866 |
|
| miR-452 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25040964 |
|
| miR-551b |
Doxorubicin (Adriamycin) |
lung cancer |
Associated |
Low |
25085901 |
|
| miR-149 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25156775 |
|
| miR-320a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25159093 |
|
| miR-29b-1 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
25174983 |
|
| miR-494 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
Low |
25226615 |
|
| miR-503 |
Doxorubicin (Adriamycin) |
hepatocellular cancer |
Sensitive |
Low |
25269574 |
|
| miR-135a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
Low |
25322930 |
|
| miR-16 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
25327162 |
|
| miR-382 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
25344865 |
|
| miR-129 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
25344911 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25368020 |
|
| miR-103 |
Doxorubicin (Adriamycin) |
gastric carcinoma |
Sensitive |
Low |
25407491 |
|
| miR-107 |
Doxorubicin (Adriamycin) |
gastric carcinoma |
Sensitive |
Low |
25407491 |
|
| miR-10a |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-1224 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-1254 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-17 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-297 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-30b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-30e |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-338 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-361 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-424 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-487b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-519b |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-520f |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-523 |
Doxorubicin (Adriamycin) |
gastric cancer |
Resistant |
High |
25407491 |
|
| miR-587 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-593 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-628 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-675 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-760 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| miR-92b |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
High |
25407491 |
|
| let-7e |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-125-1 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-141 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-196b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-200a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-31 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-370 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-429 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
Low |
25451164 |
|
| miR-576 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-760 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-765 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25451164 |
|
| miR-193a |
Doxorubicin (Adriamycin) |
bladder cancer |
Resistant |
Low |
25542424 |
|
| miR-125b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-145 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-152 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-155 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-181a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-193b |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-200c |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-222 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-29a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-320d |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-424 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-4284 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-452 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-500 |
Doxorubicin (Adriamycin) |
breast cancer |
Resistant |
High |
25562151 |
|
| miR-503 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-767 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
High |
25562151 |
|
| miR-143 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
25576341 |
|
| miR-34a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25623761 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
glioblastoma |
Resistant |
Low |
25625875 |
|
| miR-21 |
Doxorubicin (Adriamycin) |
glioblastoma |
Resistant |
Low |
25628933 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
bladder cancer |
Sensitive |
Low |
25656571 |
|
| miR-760 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25661353 |
|
| let-7a |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25669981 |
|
| let-7a |
Doxorubicin (Adriamycin) |
melanoma |
Sensitive |
Low |
25669981 |
|
| miR-10a |
Doxorubicin (Adriamycin) |
acute myeloid leukemia |
Resistant |
Low |
25687041 |
|
| miR-101 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-10a* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1226 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-1226* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1228* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1233 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1234 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-124 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-1253 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1265 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-127 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-129 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1299 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-137 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-138 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-139 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-140 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-148a |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-1538 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1539 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-15a* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-17* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-183 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-185 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-18b |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-1911 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-1911* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1915 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-1915* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-193b |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-203 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-20a |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-20a* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-20b |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-20b* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-21* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-210 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-211 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-214 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-215 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-23b* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-25* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
kidney cancer |
Sensitive |
Low |
25698578 |
|
| miR-27b |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
Low |
25698578 |
|
| miR-28 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-326 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-338 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-342 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-34c |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-367 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-371 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-372 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-379 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-380 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-409 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-455 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-485 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-495 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-503 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-513a |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-513c |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-520c |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-526a |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-577 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-606 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-620 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-621 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-625 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-634 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-635 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-639 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-642a |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-664* |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-708 |
Doxorubicin (Adriamycin) |
liver cancer |
Sensitive |
High |
25698578 |
|
| miR-769 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-802 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-885 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-886 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-891b |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-892b |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-920 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-922 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-924 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-933 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-934 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-935 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-98 |
Doxorubicin (Adriamycin) |
liver cancer |
Resistant |
High |
25698578 |
|
| miR-133a |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
25714665 |
|
| miR-326 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
25714665 |
|
| miR-301a |
Doxorubicin (Adriamycin) |
osteosarcoma |
Resistant |
Low |
25727016 |
|
| miR-7 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Sensitive |
Low |
25880778 |
|
| miR-218 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25900794 |
|
| miR-27a |
Doxorubicin (Adriamycin) |
cancer |
Resistant |
Low |
25916297 |
|
| miR-1291 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
25934574 |
|
| miR-1291 |
Doxorubicin (Adriamycin) |
pancreatic carcinoma |
Sensitive |
Low |
25934574 |
|
| miR-125b-1 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-125b-1 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-150 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-150 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-188 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-188 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-204 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-204 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-501-5P |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-501-5P |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-519 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-519 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Resistant |
High |
25973145 |
|
| miR-769 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-769 |
Doxorubicin (Adriamycin) |
neuroblastoma |
Sensitive |
High |
25973145 |
|
| miR-522 |
Doxorubicin (Adriamycin) |
colon cancer |
Sensitive |
Low |
26043974 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
osteosarcoma |
Resistant |
Low |
26079799 |
|
| miR-7 |
Doxorubicin (Adriamycin) |
small cell lung cancer |
Associated |
Low |
26108539 |
|
| miR-124 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
26115122 |
|
| miR-124 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Sensitive |
Low |
26115122 |
|
| miR-199a |
Doxorubicin (Adriamycin) |
diffuse large B-cell lymphoma |
Sensitive |
Low |
26251897 |
|
| miR-497 |
Doxorubicin (Adriamycin) |
diffuse large B-cell lymphoma |
Sensitive |
Low |
26251897 |
|
| miR-127 |
Doxorubicin (Adriamycin) |
glioma |
Resistant |
Low |
26261488 |
|
| miR-218 |
Doxorubicin (Adriamycin) |
gastric cancer |
Sensitive |
Low |
26261515 |
|
| miR-202 |
Doxorubicin (Adriamycin) |
osteosarcoma |
Resistant |
Low |
26276504 |
|
| miR-134 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
26318721 |
|
| miR-193b |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
26526790 |
|
| miR-634 |
Doxorubicin (Adriamycin) |
ovarian cancer |
Sensitive |
Low |
26576679 |
|
| miR-224 |
Doxorubicin (Adriamycin) |
breast cancer |
Sensitive |
Low |
26701615 |
|
| miR-542 |
Doxorubicin (Adriamycin) |
triple negative breast cancer |
Sensitive |
Low |
26711968 |
|
| miR-101 |
Doxorubicin (Adriamycin) |
hepatocellular carcinoma |
Sensitive |
Low |
26718267 |
|
